[Results of the clinical testing of amitriptylin and C 34,276-Ba (dibenzobicyclooctadiene derivative) in a double-blind study].
D000639:Amitriptyline / Q000627:therapeutic use*; D000873:Anthracenes / Q000627:therapeutic use*; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy; D006801:Humans; D008875:Middle Aged; D010919:Placebos; D011379:Prognosis; D011437:Propylamines / Q000627:therapeutic use; D011569:Psychiatric Status Rating Scales; D013997:Time Factors
D000873:Anthracenes; D000928:Antidepressive Agents; D010919:Placebos; D011437:Propylamines; D000639:Amitriptyline
Ergebnisse einer klinischen Prüfung von Amitriptylin und C 34,276-Ba (dibenzobicyclooctadienderivat) im Doppelblindversuch